No Data
No Data
Shandong Wit Dyne Health (000915.SZ): No plans for product price increases or mergers and acquisitions at this time.
On August 1st, Gelunhui reported that Shandong Wit Dyne Health (000915.SZ) stated on the investor interaction platform that the company has developed a core marketing strategy of "expert authority recommendation, convenient purchasing channels, and professional category education", and has formed academic promotion, business and retail, and new retail teams to sell products nationwide. The company currently has no plans to raise product prices or engage in mergers and acquisitions.
Shandong Wit Dyne Health: Summary of Half-Year Report in 2024.
Shandong Wit Dyne Health: Half-year report for the year 2024.
Shandong Wit Dyne Health (000915.SZ): Plans to distribute 10 dividends of 5 yuan for equity in mid-2024.
On July 31st, Gelunhui reported that Shandong Wit Dyne Health (000915.SZ) announced its mid-term profit distribution plan for 2024: Based on the total share capital of 234,331,485 shares as of June 30, 2024, the company will distribute cash dividends of RMB 5 per 10 shares (including tax) to all shareholders without bonus shares, nor increasing share capital through public reserves.
Shandong Wit Dyne Health (Stock Code 000915.SZ): Net income for the first half of the year was 0.332 billion yuan, a YoY increase of 3.12%.
Shandong Wit Dyne Health(000915.SZ) released its 2024 interim report, with a total operating income of 1.154 billion yuan during the reporting period, a YoY increase of 0.10%. The net income attributable to shareholders of the listed company was 0.332 billion yuan, a YoY increase of 3.12%. The net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.319 billion yuan, a YoY increase of 5.28%. The basic earnings per share were 1.42 yuan.
Earnings Working Against Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) Share Price
No Data